FIELD: medicine.
SUBSTANCE: group of inventions relates to agents for treating an infection caused by gastrointestinal bacteria. Disclosed is use of statistical copolymer GAS914:
,
where n is average degree of polymerisation, x is fraction of glycosylated monomer; and 1-x - fraction of monomer with terminal blocking structure in form of thioglycerine, in prevention or treatment in an individual of infection caused by gastrointestinal bacteria, and which is observed in blood, heart, cardiovascular system, liver, lung, respiratory tract, kidney, urinary tract, central nervous system, skin, subcutaneous tissues or surgical wounds. Also disclosed is composition and use thereof in preventing or treating an individual with gastrointestinal tract infection.
EFFECT: group of inventions provides an effective antibacterial agent.
19 cl, 4 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FOOD COMPOSITION CONTAINING IMMUNOGLOBULINS AND OLIGOSACCHARIDES | 2005 |
|
RU2385714C2 |
| FRACTION OF KERATANSULFATE OLIGOSACCHARIDES AND PHARMACEUTICAL PREPARATION CONTAINING THEREOF | 1995 |
|
RU2173154C2 |
| ADAPTATION OF INFLUENZA VIRUS H5 TO HUMAN | 2014 |
|
RU2708447C2 |
| URONIC ACID AND PROBIOTICS | 2006 |
|
RU2419445C2 |
| TREATMENT SCHEME FOR TREATMENT OF FABRY'S DISEASE, USING STABILIZED α-GALACTOSIDASE | 2018 |
|
RU2793184C2 |
| GLYCOLIPID COMPOUNDS AND USE THEREOF IN TREATING TUMOURS | 2015 |
|
RU2719486C2 |
| EDIBLE COMPOSITION CONTAINING INDIGESTIBLE OLIGOSACCHARIDES | 2005 |
|
RU2385725C2 |
| THERAPEUTIC ANTIBODIES BINDING TO LEWIS B AND LEWIS Y BIANTENNA ANTIGENS | 2019 |
|
RU2803097C2 |
| METHOD OF PRODUCING SIALYLATED OLIGOSACCHARIDES | 2007 |
|
RU2473695C2 |
| APPLICATION OF INDIGESTIBLE SACCHARIDES FOR BETTER ADAPTATION OF NEWBORNS | 2007 |
|
RU2462252C2 |
